SAN FRANCISCO, April 10, 2017 /PRNewswire/ --
The global bone densitometers market is expected to reachUSD 1.2 billion by 2025, according to a new study by Grand View Research, Inc. The growing prevalence of metabolic bone diseases is believed to be responsible for the high clinical urgency to adopt bone densitometers, thereby
(Logo: http://photos.prnewswire.com/prnh/20150105/723757 )
Moreover, presence of consistent number of health initiatives to promote awareness pertaining to osteoporosis is anticipated to broaden market growth potential over the coming years. For instance, National Osteoporosis Foundation (NOF), a government healthcare organization that conducts National Bone Health Alliance and Fracture Liaison Service (FLS) care coordination programs, is focused on elevating awareness levels pertaining to available diagnostic & treatment alternatives for osteoporosis. It also encourages training of healthcare professionals for efficient management of osteoporosis.
In addition, advent of technologically advanced devices, such as portable densitometers, is presumed to fuel their adoption in home healthcare. Other technological advancements include implementation of advanced hip assessment software into DXA systems that enabled noninvasive assessment of proximal femur structural geometry. Additional associated benefits include depiction of wide array of parameters such as skeletal mapping, hip axis length assessment, areal BMD determination, and cross-sectional area & the femoral strength index.
Browse full research report with TOC on "Bone Densitometers Market Analysis By Technology (Axial Bone Densitometry, DEXA, QCT, Peripheral Bone Densitometry, SEXA, pDEXA, RA, QUS, pQCT), By End Use (Hospitals, Clinics), And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/bone-densitometers-market
Further key findings from the report suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the bone densitometers market on the basis of technology, end use, and region:
Read Our Blog: Bone Densitometers: Tools for advanced metabolic bone disease assessment
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected]
SOURCE Grand View Research, Inc.
Subscribe to our Free Newsletters!
High blood pressure or hypertension is a chronic condition, which usually lasts a lifetime once it ...
This cancer affects men over the age of 50 years and screening with rectal examination and PSA can ...
Hyperacusis is a chronic hearing disorder characterized by an abnormal sensitivity to s ...View All